Traumatic central serous chorioretinopathy in the fellow eye
Sir, Traumatic central serous chorioretinopathy (CSC) is very rare, and there is a few previous report of traumatic CSC worldwide. [1, 2] We recently experienced a case of CSC after blunt trauma in the fellow eye, thus, herein report the case.
A 39-year-old male presented with ocular pain in his right eye following blunt trauma by a plastic ball hitting his eye 1-day earlier. At initial presentation, his best-corrected visual acuities (BCVA) was 20/25 in the right eye and 20/20 in the left eye. The intraocular pressure was 19 mmHg in both eyes. Slit-lamp examination revealed no red blood cells in the anterior chamber. Fundus examination revealed no abnormality in the right eye. An orbital computed tomography scan showed a blowout fracture of the right orbital floor with a slight dislocation of the orbital contents [ Fig. 1 ]. Optical coherence tomography (OCT) scans were performed in CSC is a multifactorial disease of unknown etiology and has been associated with type A personality, emotional stress, pregnancy, hypertension, psychopharmacological medication, and increased levels of corticosteroids. [3] There has been a suggestion that people with type A personality, who gets intensed and overwhelmed easily by stressful situations, over stimulates sympathoadrenomeullary system, consequently overproduce catecholamine, and increase the release of cortisol resulting in CSC. [4] Our case shows no immediate ophthalmologic signs in the affected eye from the first visit, but presented CSC in the unaffected eye after few days after trauma; however, there still is a possibility that CSC has occurred regardless of trauma. During the first visit interview, many factors have been considered to rule out other factors that may have caused CSC, i.e. any stressful situation, previous diagnosis of CSC, and use of steroids (oral or any other route); however, none of these factors seemed to cause CSC. Therefore, it may conclude that the trauma in the right eye caused an increase in endogenous catecholamines, affecting the opposite eye. This is the first case of blunt trauma related CSC occurring in the unaffected eye in Korea, and it is important to notice that it took less than 1 month to recover, whereas CSC, in general, is known with its slow recovery.
In conclusion, although there are no immediate signs of damage in the affected eye after blunt trauma, a careful examination of both eyes within few days followed by regular follow-up is required as CSC may occur in the opposite, unaffected eye. 
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Handheld spectral domain optical coherence tomography seems to be a must-have device for future treatment methods of hereditary maculopathies
Dear Sir, We have read with great interest the article entitled "The use of handheld spectral domain optical coherence tomography in pediatric ophthalmology practice: Our experience of 975 infants and children." [1] We thank the author for presenting their experiences with handheld spectral domain optic coherence tomography (SD-OCT). This study has showed us that SD-OCT is a revolutionary investigation for diagnosis in pediatric population. Especially, early detection of maculopathies by this device is very exciting. Hereditary maculopathies often do not give any clinical finding in the examination of children. If there could be a development in treatment of these diseases, it will be crucial to detect maculopathy early to prevent permanent photoreceptor and/or retina pigment epithelium (RPE) injuries. Hereditary maculopathies are generally genetic disorders and characterized by progressive photoreceptor and/or RPE degeneration. [2] There are promising studies about the treatment of these diseases by gene therapy. In a recent study, retinitis pigmentosa GTPase regulator gene augmentation by adeno-associated virus 2/5 vector has been shown to prevent photoreceptor degeneration. [3] However, it investigated that this therapy could only be useful when applied before degeneration of photoreceptors. Hence, if it could be possible to cure maculopathies by genetic methods, early diagnose will be very important to survive photoreceptors. Another treatment area for hereditary maculopathies is cell replacement therapy. It could be possible to transplant stem-cell-derived photoreceptor precursors to the diseased eye. There is increasing publication about this therapy. [4] If there will be possible to apply such a therapy, early diagnose, and treatment of disease will provide better outcomes and prevent amblyopia. Thus, handheld SD-OCT seems to be a must-have device for future revolutionary treatment methods in this area of ophthalmology.
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